Ishita Drugs & Industries Ltd.
Snapshot View

View in App

Prices View details >>

47.00 -0.50 ▼-1.1%

22 March 2023, 03:40:00 PM
Volume: 318

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ishitadrugs.com
Market Cap 15.38 Cr.
Enterprise Value(EV) 11.63 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 2.59 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 19.87 Trailing Twelve Months Ending 2022-12
Industry PE 31.70 Trailing Twelve Months Ending 2022-12
Book Value / Share 30.08 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.71 Calculated using Price: 51.43
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.30 Cr. 2,990,300 Shares
FaceValue 10
Company Profile
Ishita drugs & industries limited (IDIL), an Ishita Group company was incorporated in 1992, the company is listed on the local stock exchanges in India and has earned a reputation as a 'high quality manufacturer' in a very short time.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.05%
1 Week
-2.08%
1 Month
-6.00%
3 Month
-11.07%
6 Month
-22.19%
1 Year
+9.30%
2 Year
+54.10%
5 Year
+119.63%
10 Year
+170.89%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 3.95 4.12 2.47 3.19 4.17 5.64 8.18 11.25 9.82
Return on Capital Employed (%) 6.27 5.98 4.02 4.79 7.26 8.17 10.79 14.39 13.00
Return on Assets (%) 2.80 3.26 1.81 2.37 3.46 4.54 6.12 8.82 7.85

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 5 5 6 6 6 6 7 8 9 9
Non Curr. Liab. 0 0 0 0 0 0 0 0 0 0
Curr. Liab. 1 1 3 1 1 2 3 1 3 1
Minority Int.
Equity & Liab. 7 7 8 7 7 8 10 9 11 10
Non Curr. Assets 2 1 1 1 1 2 1 1 1 1
Curr. Assets 5 6 7 6 6 7 8 8 10 9
Misc. Exp. not W/O
Total Assets 7 7 8 7 7 8 10 9 11 10

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 7 7 7 6 7 9 15 14 14 13
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 7 7 7 6 7 9 15 14 14 14
Total Expenditure -6 -7 -6 -6 -6 -9 -14 -13 -13 -12
PBIDT 0 0 0 0 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 1 1 1 1
Adjusted EPS 1 1 0 1 1 1 2 3 3 3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 1 0 0 1 1 1 1 -1 3
Cash Fr. Inv. 0 0 0 0 -1 -1 -1 -1 2 -1
Cash Fr. Finan. 0 0 0 1 -1 0 0 0 0
Net Change 0 0 0 1 -1 0 0 0 2 2
Cash & Cash Eqvt 1 1 1 2 1 1 1 1 3 5

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 47.87 47.87 47.87 47.87 48.37 49.31 49.32 49.32 49.32
Public 52.13 52.13 52.13 52.13 51.63 50.69 50.68 50.68 50.68
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 14 Feb 2023
Unaudited Financial Results For The Quarter Ended 31St December 2022 Approved In Our Board Meeting Held On 14Th February 2023
Pursuant to the regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that the Board of Directors of Ishita Drugs and Industries Limited at its meeting held today i.e.14th February 2023 have Approved the Unaudited Financial Results along with Limited Review Report by Statutory Auditors of the Company for the quarter ended 31st December 2022.
Tue, 14 Feb 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th February 2023
Pursuant to the regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that the Board of Directors of Ishita Drugs and Industries Limited at its meeting held today i.e.14th February 2023 have Approved the Unaudited Financial Results of the Company along with the limited review report by Statutory Auditor for the quarter ended 31st December 2022.
Tue, 07 Feb 2023
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 And Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter Ended 31St December 2022
ISHITA DRUGS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve Notice is hereby given that pursuant to Regulation 29 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of the Company will be held on Tuesday 14th February 2023 to transact the following business:1. To consider approve and take on record the Unaudited Financial Results of the Company for the quarter ended 31st December 2022. 2. Any other matter with permission of the Chair.

Technical Scans View Details >>

Tue, 21 Mar 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Opening at Low Opening at Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 6 Months High Decrease in 6 Months

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 229,424.41 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. 73,593.21 4,474.95 +1.3%
Divi's Laboratories Ltd. 73,553.38 2,790.65 +0.8%
Cipla Ltd. 69,632.88 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. 61,491.67 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. 51,277.87 1,518.60 +0.2%
Zydus Lifesciences Ltd. 48,378.30 478.65 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.47 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.20 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 30.72 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-12 26.39 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.34 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.82 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.47 478.65 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.15 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.34 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 5.92 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-12 3.07 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.80 478.65 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-03 0.04 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 478.65 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 478.65 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 478.65 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 478.65 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 478.65 +0.1%

FAQ's On Ishita Drugs & Industries Ltd.

What is Ishita Drugs & Inds. share price?
Can I buy Ishita Drugs & Inds. shares now?
What is the Market Cap of Ishita Drugs & Inds.?
What are the key metrics to analyse Ishita Drugs & Inds.?
What is the 52 Week High and Low of Ishita Drugs & Inds.?
What is the trend of Ishita Drugs & Inds. share price?